510(k) K810967

IN-VITRO TBG RADIOIMMUNOASSAY TEST by Clinical Assays, Inc. — Product Code CEE

K810967 is an FDA 510(k) premarket notification submitted by Clinical Assays, Inc. for the device "IN-VITRO TBG RADIOIMMUNOASSAY TEST". The FDA issued a decision of Substantially Equivalent on Apr 23, 1981. The device falls under product code CEE (Radioimmunoassay, Thyroxine-Binding Globulin), a Class II device regulated under 21 CFR 862.1685. Clinical Assays, Inc. has 26 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Apr 23, 1981
Date Received
Apr 8, 1981
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Radioimmunoassay, Thyroxine-Binding Globulin
Device Class
Class II
Regulation Number
862.1685
Review Panel
CH
Submission Type
510(k) Exempt

Need the full FDA record for Clinical Assays, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K810967. Report a data issue: hello@regdatalab.com.